UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 771

Sortiert nach

The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists

Current medicinal chemistry, 2007-04, Vol.14 (8), p.917

2007

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease

Osteoarthritis and cartilage, 2010-10, Vol.18 (10), p.1319-1328

2010

Link zum Volltext

Verfügbarkeit prüfen

Cell death in the superficial dorsal horn in a model of neuropathic pain

Journal of neuroscience research, 2001-04, Vol.64 (2), p.168-173

2001

Link zum Volltext

Verfügbarkeit prüfen

Species‐specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers

British journal of pharmacology, 2007-08, Vol.151 (7), p.1061-1070

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Neuropharmacology, 2005-04, Vol.48 (5), p.658-672

2005

Link zum Volltext

Verfügbarkeit prüfen

Measuring and realizing the translational significance of preclinical in vivo studies of painful osteoarthritis

Osteoarthritis and cartilage, 2017-03, Vol.25 (3), p.376-384

2017

Link zum Volltext

Verfügbarkeit prüfen

WAY‐318068: a novel, potent and selective noradrenaline re‐uptake inhibitor with activity in rodent models of pain and depression

British journal of pharmacology, 2010-07, Vol.160 (5), p.1105-1118

2010

Link zum Volltext

Verfügbarkeit prüfen

Predictive validity of animal pain models? A comparison of the pharmacokinetic–pharmacodynamic relationship for pain drugs in rats and humans

Neuropharmacology, 2008-04, Vol.54 (5), p.767-775

2008

Link zum Volltext

Verfügbarkeit prüfen

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression

Neuropharmacology, 2013-03, Vol.66, p.202-214

2013

Link zum Volltext

Verfügbarkeit prüfen

Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb

Bone (New York, N.Y.), 2006-03, Vol.38 (3), p.387-393

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological characterisation of a rat model of incisional pain

British journal of pharmacology, 2004-01, Vol.141 (1), p.85-91

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of colchicine on neuropeptide Y expression in rat dorsal root ganglia and spinal cord

Neuroscience letters, 1999-01, Vol.259 (1), p.45-48

1999

Link zum Volltext

Verfügbarkeit prüfen

0001 Activation of Nociceptin/Orphanin-FQ Peptide (NOP) Receptors Produces an Increase in Non-REM Sleep in Rats and Constitutes a Novel and Attractive Target for the Treatment of Insomnia

Sleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A1-A1

2020

Link zum Volltext

Verfügbarkeit prüfen

Species‐specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers

British journal of pharmacology, 2007-08, Vol.151 (7), p.1137-1137

2007

Link zum Volltext

Verfügbarkeit prüfen

Extraction of Tree Crowns from High Resolution Imagery over Eucalypt Dominant Tropical Savannas

Photogrammetric engineering and remote sensing, 2011-08, Vol.77 (8), p.813-824

2011

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Cytokine and Chemokine Expression Is Differentially Modulated Acutely in the Dorsal Root Ganglion in Response to Different Nerve Root Compressions

Spine (Philadelphia, Pa. 1976), 2011-02, Vol.36 (3), p.197-202

2011

Link zum Volltext

Verfügbarkeit prüfen

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833

European journal of pharmacology, 2005-12, Vol.528 (1-3), p.65-72

2005

Link zum Volltext

Verfügbarkeit prüfen

The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid)

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1234

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states

The Journal of pharmacology and experimental therapeutics, 2006-09, Vol.318 (3), p.1083

2006

Link zum Volltext

Verfügbarkeit prüfen

DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat

The Journal of pharmacology and experimental therapeutics, 2004-08, Vol.310 (2), p.793

2004

Link zum Volltext

Verfügbarkeit prüfen

No Small Matter: Science on the Nanoscale

1, 2009

Link zum Volltext

Verfügbarkeit prüfen

Good prospects for Lab on a Chip

Journal of environmental monitoring, 2008-11, Vol.10 (11), p.C88-C88

2008

Link zum Volltext

Verfügbarkeit prüfen

Therapist's Guide to Evidence-Based Relapse Prevention

1, 2011

Link zum Volltext

Verfügbarkeit prüfen

The lung microbiome: progress and promise

The Journal of clinical investigation, 2021-08, Vol.131 (15)

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparing object-based and pixel-based classifications for mapping savannas

International journal of applied earth observation and geoinformation, 2011-12, Vol.13 (6), p.884-893

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 771

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(667)
Mit Volltextzugriff
(595)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists

Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease

Cell death in the superficial dorsal horn in a model of neuropathic pain

Species‐specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Measuring and realizing the translational significance of preclinical in vivo studies of painful osteoarthritis

WAY‐318068: a novel, potent and selective noradrenaline re‐uptake inhibitor with activity in rodent models of pain and depression

Predictive validity of animal pain models? A comparison of the pharmacokinetic–pharmacodynamic relationship for pain drugs in rats and humans

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression

Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb

Pharmacological characterisation of a rat model of incisional pain

Effect of colchicine on neuropeptide Y expression in rat dorsal root ganglia and spinal cord

0001 Activation of Nociceptin/Orphanin-FQ Peptide (NOP) Receptors Produces an Increase in Non-REM Sleep in Rats and Constitutes a Novel and Attractive Target for the Treatment of Insomnia

Species‐specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers

Extraction of Tree Crowns from High Resolution Imagery over Eucalypt Dominant Tropical Savannas

Inflammatory Cytokine and Chemokine Expression Is Differentially Modulated Acutely in the Dorsal Root Ganglion in Response to Different Nerve Root Compressions

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833

The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid)

Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states

DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat

No Small Matter: Science on the Nanoscale

Good prospects for Lab on a Chip

Therapist's Guide to Evidence-Based Relapse Prevention

The lung microbiome: progress and promise

Comparing object-based and pixel-based classifications for mapping savannas

Suchergebnisse filtern